These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15328901)

  • 41. [Olanzapine--high potency antipsychotic drug inducing significant weight gain: a case report].
    Marić N; Josifović-Kostić D; Vuković O; Britivić D; Jasović-Gasić M
    Srp Arh Celok Lek; 2008; 136(5-6):284-8. PubMed ID: 18792627
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Weight gain and antipsychotic medications.
    Aquila R; Emanuel M
    J Clin Psychiatry; 1999 May; 60(5):336-7. PubMed ID: 10362443
    [No Abstract]   [Full Text] [Related]  

  • 43. Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management.
    Stigler KA; Potenza MN; Posey DJ; McDougle CJ
    Paediatr Drugs; 2004; 6(1):33-44. PubMed ID: 14969568
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis.
    Strassnig M; Miewald J; Keshavan M; Ganguli R
    Schizophr Res; 2007 Jul; 93(1-3):90-8. PubMed ID: 17478082
    [TBL] [Abstract][Full Text] [Related]  

  • 45. H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.
    Kroeze WK; Hufeisen SJ; Popadak BA; Renock SM; Steinberg S; Ernsberger P; Jayathilake K; Meltzer HY; Roth BL
    Neuropsychopharmacology; 2003 Mar; 28(3):519-26. PubMed ID: 12629531
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug induced weight gain, an impediment to successful pharmacotherapy: focus on antipsychotics.
    Baptista T; Zárate J; Joober R; Colasante C; Beaulieu S; Páez X; Hernández L
    Curr Drug Targets; 2004 Apr; 5(3):279-99. PubMed ID: 15058313
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dopamine receptor D2 gene is associated with weight gain in schizophrenic patients under long-term atypical antipsychotic treatment.
    Hong CJ; Liou YJ; Bai YM; Chen TT; Wang YC; Tsai SJ
    Pharmacogenet Genomics; 2010 Jun; 20(6):359-66. PubMed ID: 20375926
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insulin and leptin levels in patients with schizophrenia or related psychoses--a comparison between different antipsychotic agents.
    Melkersson KI; Hulting AL
    Psychopharmacology (Berl); 2001 Mar; 154(2):205-12. PubMed ID: 11314683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
    Lieberman JA; Stroup TS; McEvoy JP; Swartz MS; Rosenheck RA; Perkins DO; Keefe RS; Davis SM; Davis CE; Lebowitz BD; Severe J; Hsiao JK;
    N Engl J Med; 2005 Sep; 353(12):1209-23. PubMed ID: 16172203
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trajectories of agouti-related protein and leptin levels during antipsychotic-associated weight gain in patients with schizophrenia.
    Ehrlich S; Leopold K; Merle JV; Theophil I; Haag W; Lautenschlager M; Schaefer M
    J Clin Psychopharmacol; 2012 Dec; 32(6):767-72. PubMed ID: 23131879
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Two models for weight gain and hyperphagia as side effects of atypical antipsychotics in male rats: validation with olanzapine and ziprasidone.
    Shobo M; Yamada H; Mihara T; Kondo Y; Irie M; Harada K; Ni K; Matsuoka N; Kayama Y
    Behav Brain Res; 2011 Jan; 216(2):561-8. PubMed ID: 20816897
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aripiprazole versus other atypical antipsychotics for schizophrenia.
    Khanna P; Komossa K; Rummel-Kluge C; Hunger H; Schwarz S; El-Sayeh HG; Leucht S
    Cochrane Database Syst Rev; 2013 Feb; (2):CD006569. PubMed ID: 23450570
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term treatment with atypical antipsychotics and the risk of weight gain : a literature analysis.
    Gentile S
    Drug Saf; 2006; 29(4):303-19. PubMed ID: 16569080
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of clozapine-associated weight gain: a systematic review.
    Whitney Z; Procyshyn RM; Fredrikson DH; Barr AM
    Eur J Clin Pharmacol; 2015 Apr; 71(4):389-401. PubMed ID: 25627831
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel antipsychotics: comparison of weight gain liabilities.
    Wirshing DA; Wirshing WC; Kysar L; Berisford MA; Goldstein D; Pashdag J; Mintz J; Marder SR
    J Clin Psychiatry; 1999 Jun; 60(6):358-63. PubMed ID: 10401912
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone.
    Lee SY; Park MH; Patkar AA; Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):490-6. PubMed ID: 21146575
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
    Stip E; Tourjman V
    Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of weight gain in patients with schizophrenia.
    Aquila R
    J Clin Psychiatry; 2002; 63 Suppl 4():33-6. PubMed ID: 11913674
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential metabolic effects of antipsychotic treatments.
    Haupt DW
    Eur Neuropsychopharmacol; 2006 Sep; 16 Suppl 3():S149-55. PubMed ID: 16872808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.